Canada markets closed

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.5200-0.0100 (-0.65%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-9,890
-17,748
-17,424
-17,082
Depreciation & amortization
3.61
4
4.126
8.907
Stock based compensation
1,055
735
314.65
325.523
Change in working capital
2,757
822
-1,984
-55.629
Other working capital
-17,455
-21,504
-18,847
-16,950
Other non-cash items
142
-
-
900
Net cash provided by operating activites
-17,455
-21,504
-18,847
-16,950
Cash flows from financing activities
Common stock issued
16,329
25,194
14,293
25,046
Net cash used privided by (used for) financing activities
16,424
25,288
14,293
25,074
Net change in cash
-970.489
3,889
-4,695
8,324
Cash at beginning of period
8,151
9,361
14,056
5,732
Cash at end of period
7,121
13,250
9,361
14,056
Free Cash Flow
Operating Cash Flow
-17,455
-21,504
-18,847
-16,950
Free Cash Flow
-17,455
-21,504
-18,847
-16,950